Beek Jeroen B. Van

Companies

• Kalaris Therapeutics, Inc.Chief Commercial Officer Jul 30, 2020 to Nov 18, 2022¹
• TricidaChief Comm Officer and Sr VP Jun 27, 2018 to Jul 2, 2018²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• KTKalaris Therapeutics, Inc. KLRS333,726 shares³$637.4K at $1.91Nov 16, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

• Nov 16, 2022Sold 16,074 shares at $7.50 of Kalaris Therapeutics, Inc.³
• Nov 11, 2022Sold 36,592 shares at $8.20 of Kalaris Therapeutics, Inc.⁴
• Nov 10, 2022Sold 13,109 shares at $8.00 of Kalaris Therapeutics, Inc.⁵
• Nov 8, 2022Sold 299 shares at $8.00 of Kalaris Therapeutics, Inc.⁵
• Oct 20, 2022Sold 1,070 shares at $9.36 of Kalaris Therapeutics, Inc.⁶
• Oct 19, 2022Sold 1,070 shares at $9.36 of Kalaris Therapeutics, Inc.⁷
• Sep 2, 2022Sold 493 shares at $7.89 of Kalaris Therapeutics, Inc.⁸
• Aug 16, 2022Granted 15,000 shares of Kalaris Therapeutics, Inc.⁹
• Aug 16, 2022Sold 15,590 shares at $8.30 of Kalaris Therapeutics, Inc.⁹
• Jul 20, 2022Sold 1,058 shares at $5.21 of Kalaris Therapeutics, Inc.¹⁰
• Jul 1, 2022Granted 14,000 shares of Kalaris Therapeutics, Inc.¹¹
• Jun 3, 2022Sold 515 shares at $3.63 of Kalaris Therapeutics, Inc.¹¹
• May 17, 2022Sold 15,262 shares at $4.40 of Kalaris Therapeutics, Inc.¹²
• Apr 20, 2022Sold 852 shares at $6.68 of Kalaris Therapeutics, Inc.¹³
• Mar 2, 2022Sold 516 shares at $9.01 of Kalaris Therapeutics, Inc.¹⁴
• Feb 16, 2022Sold 15,322 shares at $8.32 of Kalaris Therapeutics, Inc.¹⁵
• Jan 20, 2022Sold 4,656 shares at $8.75 of Kalaris Therapeutics, Inc.¹⁶
• Jan 18, 2022Granted 23,256 shares of Kalaris Therapeutics, Inc.¹⁷
• Dec 2, 2021Sold 514 shares at $17.06 of Kalaris Therapeutics, Inc.¹⁸
• Nov 16, 2021Sold 15,203 shares at $21.13 of Kalaris Therapeutics, Inc.¹⁹
• Oct 1, 2021Sold 3,413 shares at $25.07 of Kalaris Therapeutics, Inc.²⁰
• Sep 30, 2021Sold 12,171 shares at $25.17 of Kalaris Therapeutics, Inc.²⁰
• Sep 29, 2021Sold 1,000 shares at $25.04 of Kalaris Therapeutics, Inc.²⁰